Angle Share Discussion Threads

[ohwhatfun] 27/4/2024 13:42

Ht

Fantasy highly unlikely, hence no comment. The whole company is loose change to them, why do the current deal, just acquire AGL.

Random trashing is one thing, putting the pieces together is another.

AGL have given their max timeline to cash running out based on all things going to plan. So the chat about funding needed isn’t fiction, it’s fact.

You can’t leave it until late in the day. The share price just had a boost, if nothing else substantial is imminent then best crack on and get it done, results first though.

[htrocka2] 27/4/2024 10:09

ohwhatfun...you never answered my question....With AZ's current involvement with AGL, what signals would be sent out if AZ took up the majority of any proposed placing?.

[ohwhatfun] 27/4/2024 09:33

Ht

The market/city doesn’t care, max discount for max gains, what AGL do is not of interest to market makers.

In other news
Some are lurking investors not salivating shorters.

AGL took its time but traction finally appearing, the historic cash burn does seem high though.

It will be good to get the raise out of the way, bound to be some angry PIs if the market does to AGL (likely) what it has done to near all other small caps in recent times.

[nigelpm] 27/4/2024 09:33

Funding will be likely needed but quite how a trial with AZ is somehow seen as a problem is beyond me.. at a market cap around 38m you get a lot of potential upside.

[htrocka2] 27/4/2024 09:09

'Interims warned of a slowing market,'

Whoopee!....breast cancer has be eliminated...( just looking at this from a different perspective)

ps...10p cash placing?...should this happen, I wonder how many AZ will take up?.

[ohwhatfun] 27/4/2024 08:29

Really

Regularly the doom crew work on unfounded points, fictional scare tactics hence the checking of their claims.

On this occasion much of what they say is correct.
AGL have stated slow going, need funds, with the timeline assuming cost savings achieved. Given the slow going point, it’s not unreasonable to consider the cash will only last until year end.

Thus funding likely needed before the end of June, latest (all things going to plan) end of Sept.

Typically as results are close, potential backers will want to see those pre decision making.

Going by a plethora of heavily discounted raises in the last year, suggesting 10p, is generous, under 10p is more likely if revenue is slow and no significant monetary news prior.

[ohwhatfun] 27/4/2024 07:58

Did they actually forecast £6m additional revenue in news (I couldn’t see it) or is that just note fluff?

[bones699] 27/4/2024 07:49

Financials when eventually released will look diasterous and no doubt the focus will be on cash burn and likely placement with the share price no doubt crashing 20% or more on results release day..

The RNS's look like a desperate ramping attempt to pre empt the poor results and likely cash raise to try and keep the share price up to minimise share holder dilution...sub 10p cash placement now firmly on the cards and RNS's spouting tiny £150k deals don't cut the mustard imho!..

Newlands finger wagging £6m additional revenues needed to extend the cash run way till Q2 next year now look like nothing more than hot air and bluster!

[ohwhatfun] 27/4/2024 07:42

News caught attention but the doomsayers look right. It’s good to see such warnings of earnings forecast failures and pending results. It protects against blind buying on news

More on the point of the savage market than AGL prospects.

The doom side prompts fact checking.

Interims warned of a slowing market, revenue not hit. Cost savings if achieved take cash INTO Q2 IE in reality is the end Q1, WITH the savings.
The slowing market or incomplete savings could mean end of Q4.

Funding typically to be at least 6 months min before the cash runs out. So either way by the end of June or up to Sept.

Results out last year April 21, any funding likely to come after results.

It appears from posts and slowing revenue that a missed forecast is in play, which will be in news to come.

Probabilities from prior news and lack of revenue support a missed forecast and likely a raise before the end of June, likely post results.

Raise at a post share price drop, market manipulation game. That game includes raising the share price to forward sell to retail investors, then drag it back in knowledge of the fund raise and close out their position in the raise.

So with the known news, likely missed forecasts and a predictable timeline to raise funds, it’s looks like a very bad call to buy now.

I see the £150k comment mentioned as irrelevant. It is not irrelevant in terms of cash in the bank and the likely impact on the fund raise price.
Potential backers will use the derisory amount as leverage.

Time will tell but on balance the doom crew crew have the best argument, based on the information available and market circumstances.

Sadly a 10p raise or lower is likely.

[5oletrader] 26/4/2024 15:52

RISKs of SECOND primary cancers among 584,965 female and male BREAST cancer survivors in England - a 25 YEAR retrospective cohort STUDY.Https://www.thelancet.com/journals/lanepe/article/PIIS2666-7762(24)00069-3/fulltext- "It's IMPORTANT for us to understand to what extent having one type of cancer puts you at RISK of a SECOND cancer at a different site. The female and male BREAST cancer survivors whose data we studied were at INCREASED RISK of a number of SECOND cancers. KNOWING this can HELP inform conversations with their care teams to look out for SIGNS of potential new cancers."Https://www.cam.ac.uk/research/news/study-highlights-increased-risk-of-second-cancers-among-breast-cancer-survivors-25 YEARS of STRONG EVIDENCE!!!Reaffirms the NEED for regular screening + ANGLE having FDA approval in BREAST cancer - could it mean tests 'FOR PATIENTS' are in the not too distant future?25 years of evidence says we need it!

[donald pond] 26/4/2024 10:02

Five trades reported as sells which look like a cunningly disguised rollover

[robizm] 26/4/2024 10:00

Until the sell on the spike pack start selling. They have bought at 13.5p so soon they will go for the profit then rinse and repeat.

[kirk 6] 26/4/2024 09:58

This is going to rocket

[citys2874] 26/4/2024 09:37

in the top 25 gainers on the leaderboard moving up nicely and mms ready to tick up again

[washingmachine] 26/4/2024 09:26

Wait for results imo

[zeus19] 26/4/2024 09:25

Thats too much information for her tiny brain

[5oletrader] 26/4/2024 09:13

@699 maybe highlight the caveat to this 'tiny deal' - as the below means nothing does it:• The collaboration gives ANGLE the POTENTIAL to EXPAND their services in oncology trials. The initial phase of the contract is valued at £150,000, but it holds SUBSTANTIAL POTENTIAL due to the possibility of implementing a new assay in NUMEROUS cancer TRIALS involving AstraZeneca. • Furthermore, the collaboration includes the development of assays for examining proteins on cancer cells across multiple trials, with POTENTIAL EARNINGS of £2,000 per time point in over 460 trials involving 140,000 patients.• ?140,000 patients x £2,000 = £280M• ?£280M x 3 time points = £840M-In effect ANGLE have opened the door to a 840 MILLION QUID BUSINESS OPPORTUNITY with just AstraZeneca. Want to do the maths on EISAI trials too?

[boris cobaka] 26/4/2024 09:06

Results due soonish?

[citys2874] 26/4/2024 09:02

In the top 40 gainers now on the leaderboard and mms are ready to tick up once again

[donald pond] 26/4/2024 09:01

Looking interesting here. Buys coming in, needs more volume of course

[citys2874] 26/4/2024 09:01

strong buying coming in now and gaining good momentum can we see a happy Friday and see this in the high teens this afternoon

[zeus19] 26/4/2024 08:40

Suppliers? Again just shows how uneducated you are